Clinical Trials Directory

Trials / Conditions / Achromatopsia

Achromatopsia

12 registered clinical trials studyying Achromatopsia — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingNatural History Study of Inherited Retinal Diseases
NCT07085533
Zhongmou Therapeutics—
SuspendedPBA Use for Treatment of ATF6-/- Patients
NCT04041232
Columbia UniversityEARLY_Phase 1
CompletedGene Therapy for Achromatopsia (CNGA3)
NCT03758404
MeiraGTx UK II LtdPhase 1 / Phase 2
Active Not RecruitingSafety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
NCT02935517
Beacon TherapeuticsPhase 1 / Phase 2
TerminatedLong-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3
NCT03278873
MeiraGTx UK II Ltd—
CompletedGene Therapy for Achromatopsia (CNGB3)
NCT03001310
MeiraGTx UK II LtdPhase 1 / Phase 2
Active Not RecruitingSafety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial)
NCT02599922
Beacon TherapeuticsPhase 1 / Phase 2
Active Not RecruitingSafety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia
NCT02610582
STZ eyetrialPhase 1 / Phase 2
RecruitingInherited Retinal Degenerative Disease Registry
NCT02435940
Foundation Fighting Blindness—
CompletedClinical and Genetic Characterization of Individuals With Achromatopsia
NCT01846052
Beacon Therapeutics—
CompletedCNTF Implants for CNGB3 Achromatopsia
NCT01648452
National Eye Institute (NEI)Phase 1 / Phase 2
CompletedNatural History Study for Achromatopsia
NCT04124185
MeiraGTx UK II Ltd—